James D. Otvos

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where James D. Otvos is active.

Explore More

Publication

Featured researches published by James D. Otvos.

Archive | 2000

James D. Otvos; Dennis W. Bennett

Archive | 2013

James D. Otvos; Irina Shalaurova; Dennis W. Bennett; Justyna Wolak-Dinsmore

Archive | 2013

James D. Otvos; Irina Shalaurova; Dennis W. Bennett; Justyna Wolak-Dinsmore; Thomas M. O'Connell; Kelly Mercier

Archive | 2013

Thomas M. O'Connell; Kelly Mercier; Irina Shalaurova; James D. Otvos

Archive | 2013

James D. Otvos; Irina Shalaurova; Dennis W. Bennett; Justyna Wolak-Dinsmore

Archive | 2013

James D. Otvos; Irina Shalaurova

Archive | 2013

James D. Otvos; Elias J. Jeyarajah; Justyna Wolak-Dinsmore; Thomas M. O'Connell; Dennis W. Bennett; Steven P. Matyus; Stanley L. Hazen

Archive | 2016

James D. Otvos; Irina Shalaurova

Archive | 2015

James D. Otvos; Irina Shalaurova

Archive | 2013

James D. Otvos; Irina Shalaurova

Explore More

Collaboration

Dive into the James D. Otvos's collaboration.

Top Co-Authors

Irina Shalaurova

North Carolina State University

View shared research outputs

Top Co-Authors

Dennis W. Bennett

University of Wisconsin–Milwaukee

View shared research outputs

Top Co-Authors

Elias J. Jeyarajah

North Carolina State University

View shared research outputs

Top Co-Authors

Stanley L. Hazen

Cleveland Clinic

View shared research outputs

Explore More

University of North Carolina at Chapel Hill

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot

Dive into the research topics where James D. Otvos is active.

Publication

Featured researches published by James D. Otvos.

Nmr-method for determining the risk of developing type 2 diabetes

Nmr measurements of glyca

Multi-parameter diabetes risk evaluations

Nmr quantification of branched chain amino acids

NMR Measurements of NMR Biomarker GlycA

PROTECTIVE HDL PARTICLE NUMBER EVALUATIONS

Nmr quantification of tmao

CARDIOVASCULAR RISK EVALUATIONS USING A RISK PARAMETER THAT INCLUDES AN HDL AND INFLAMMATORY BIOMARKER INTERACTION PARAMETER

MULTIPLE-MARKER RISK PARAMETERS PREDICTIVE OF CONVERSION TO DIABETES

CHD RISK STRATIFICATION EVALUATIONS FOR SUBJECTS WITH HIGH LEVELS OF LARGE HDL -P

Collaboration

Dive into the James D. Otvos's collaboration.